Keeping up with medical ‘truth’ 
It’s now documented: by the time you retire, half of what you learned in medical school will be false or obsolete.
J.D. CLOUGH

  ‘White coat hypertension’—should it be treated or not?
Treatment is controversial, and any benefit of treatment is unproven.
T. PICKERING

Hyperuricemia and gout: A reign of complacency
We physicians have become complacent about gouty arthritis, developing a false sense of confidence that we actually know how to manage it.
B.F. MANDELL

Asymptomatic hyperuricemia: To treat or not to treat
Most people with asymptomatic hyperuricemia do not need further workup or treatment. Who are the exceptions?
H.E. DINCER, A.P. DINCER, and D.J. LEVINSON

Progress in preventing chemotherapy-induced nausea and vomiting
Our understanding of the pathophysiology of emesis has improved, and we now have drugs that can prevent acute emesis in most patients. Delayed and anticipatory emesis remain a challenge.
M. MARKMAN

Inflammatory bowel disease: Sorting out the treatment options
Options now include aminosalicylates, steroids, azathioprine, 6-mercaptopurine, cyclosporine, methotrexate, infliximab, heparin, and perhaps even antimicrobials and nicotine. How to choose?
J.M. WOLF and B.A. LASHNER

A 62-year-old man with hypotension and an abnormal chest radiograph
What is the cause of this patient’s symptoms? A self-test.
K.M. CHAN-TACK, S. STANDRIDGE, and E. ADELSTEIN

Two advances in the management of Parkinson disease
Second-generation dopamine agonists may be preferable to levodopa early in the disease. Deep brain stimulation is remarkably effective in refractory cases.
E.B. MONTGOMERY, Jr.

Endometriosis: Still tough to diagnose and treat
Despite advances, endometriosis is still tough to diagnose, treat, and live with.
M. ATTARAN, T. FALCONE, and J. GOLDBERG